TALPHERA, INC. Income (Loss) from Continuing Operations, Per Diluted Share
TALPHERA, INC. (TLPH) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.10 per share for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2025-05-14
- TALPHERA, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2025-03-31 was -$0.10.
- TALPHERA, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2024-03-31 was -$0.16.
- TALPHERA, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2023-09-30 was -$0.08.
- TALPHERA, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2023-06-30 was -$0.41, a 104.52% decline year-over-year.
- TALPHERA, INC. income (loss) from continuing operations, per diluted share for fiscal 2023 was -$0.72, a 109.93% decline from fiscal 2022.
- TALPHERA, INC. income (loss) from continuing operations, per diluted share for fiscal 2022 was $7.25.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|
| 2025-03-31 | -$0.10 10-Q · filed 2025-05-14 | |||
| 2024-03-31 | -$0.16 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | -$0.72 10-K · filed 2024-03-06 | |||
| 2023-09-30 | -$0.08 10-Q · filed 2023-11-14 | -$0.45 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | -$0.41 10-Q · filed 2023-08-10 | -$0.40 10-Q · filed 2023-08-10 | ||
| 2022-12-31 | $7.25 10-K · filed 2024-03-06 | |||
| 2022-09-30 | -$0.65 10-Q · filed 2023-11-14 | $8.02 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $9.08 10-Q · filed 2023-08-10 | $8.62 10-Q · filed 2023-08-10 | ||
| 2021-12-31 | -$2.86 8-K · filed 2023-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |